Oral thrush to Candidemia: A morbid outcome

Journal of the International Association of Physicians in AIDS Care

Volumn 9, Issue 5, 2010, Pages 325-327

  Gautam, Hitender ^a   Kaur, Ravinder ^a   Goyal, Ritu ^a   Bhalla, Preena ^a   Dewan, Richa ^a  

^a LOK NAYAK HOSPITAL   (India)

Author keywords

candidemia; oral thrush

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIFUNGAL SUSCEPTIBILITY; ANTIGEN DETECTION; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; BROTH DILUTION; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS; CASE REPORT; CD4+ T LYMPHOCYTE; COMORBIDITY; DEATH; DNA FINGERPRINTING; DRUG EFFECT; FEMALE; FEVER; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FUNGAL STRAIN; FUNGUS HYPHAE; FUNGUS ISOLATION; HIGH RISK PATIENT; HIV TEST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPTIC SHOCK; SEROLOGY; THRUSH; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS CULTURE; VIRUS LOAD; WEIGHT REDUCTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDEMIA; CANDIDIASIS, ORAL; DRUG RESISTANCE, FUNGAL; FATAL OUTCOME; FEMALE; FLUCONAZOLE; HIV-1; HUMANS; SHOCK, SEPTIC;

EID: 78650828892     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109710373827     Document Type: Article

References (13)

1. Cheng MF, Yang YL, Yao TJ, et al. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis. 2005 ; 5 (1). 22.
2. Cheng YR, Lin LC, Toung TG, Liu CE, Chen CH, Tsay RW Risk factors for Candidemia-related mortality at a medical centre in central Taiwan. J Microbiol Immunol Infect. 2006 ; 39 (2). 155-161.
3. Tumarello M., Tacconelli E., de Gaetano Donati K., Morace G., Fadda G., Cauda R. Candidemia in HIV-infected subjects. Eur J Clin Microbiol Infect Dis. 1999 ; 18 (7). 478-483.
4. World Health Organization. Anti-Retroviral Therapy Guidelines for HIV-Infected Adults and Adolescents Including Post-Exposure Prophylaxis. New Delhi, India: NACO, Ministry of Health & Family Welfare, Government of India ; 2007.
5. Forbes BA, Sahm DF, Weissfeld AS Bailey and Scott's ''Diagnostic Microbiology''. 11th ed. St Louis, MO: Mosby Inc ; 2002.
6. Mosaid AA, Sullivan D., Salkin IF, Shanley D., Coleman DC Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol. 2001 ; 39 (1). 323-327.
7. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards ; 2002.
8. Mukhopadhyay K., Prasad T., Saini P., Pucadyil TJ, Chattopadhyay A., Prasad R. Membrane sphingolipidergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob Agents Chemother. 2004 ; 48 (5). 1778-1787.
9. Girishkumar H., Yousuf AM, Chivate J., Geisler E. Experience with invasive Candida infections. Postgrad Med J. 1999 ; 75 (881). 151-153.
10. Bennett JE Candidiasis. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principle of Internal Medicine. 1 6 th ed. New York, NY: McGraw Hill ; 2005: 1186-1188.
11. Launay O., Lortholary O., Bouges-Michel C., Jarrousse B., Bentata M., Guillevin L. Candidemia: a nosocomial complication in adults with late-stage AIDS. Clin Infect Dis. 1998 ; 26 (5). 1134-1141.
12. Bertagnolio S., de Gaetano Donati K., Tacconelli E., et al. Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. J Chemother. 2004 ; 16 (2). 172-178.
13. Guidelines for prevention and management of common opportunistic infections/malignancies among HIV-infected adult and adolescent. New Delhi, India: NACO, Ministry of Health & Family Welfare, Government of India ; May 2007.